Axol Bioscience and Censo Biotechnologies merge to boost iPSC-related technologies
Axol Bioscience, a provider of iPSC-derived cells, media, and characterization services, and CENSO Biotechnologies, a cell biology CRO with focused expertise in iPSC-related technologies, have merged.